GET LISTED | LOGIN | SIGNUP
 
Welcome to FindMyBest CPA
 
Accounting & Financial Directory
 
Find local and nationwide accounting and financial businesses. We have located the best Accountants, CPAs, Accounting Firms, Tax Consultants, Tax Return Preparers, Bookkeepers and Financial Advisors in the US.
 
Business Directory
 
Becton, Dickinson and Company Detail
 
 
 
 
 
Fortune 500 Company List


Becton, Dickinson and Company

Stock Symbol: BDX

1 Becton Drive
http://www.bd.com

Becton, Dickinson and Company Industry:
Medical Equipment & Supplies

Becton, Dickinson and Company Description:
BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. For the fiscal year ended September 30, 2002, BD reported total revenues of $4.033 billion.

Becton, Dickinson and Company Financial Summary:
BDX manufactures and sells a broad line of supplies, devices and systems used by health care professionals, medical research institutions and the general public. For the 9 months ended 6/30/05, revenues rose 10% to $4.04B. Net income from cont. ops. applic. to Com. rose 43% to $570.7M. Revenues reflect higher sales of safety engineered products and the favorable impact of currency translation. Earnings also reflect increased gross profit margin.

Becton, Dickinson and Company Business Summary:
Becton, Dickinson and Company (BD) is a medical technology company engaged principally in the manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD's operations consist of three worldwide business segments: BD Medical, BD Diagnostics and BD Biosciences. In July 2004, BD acquired Atto Bioscience, Inc. (Atto), a privately held company specializing in optical instrumentation, software and reagents for real-time analysis of interactions taking place in living cells. In September 2004, the Company decided to sell the Clontech unit of the BD Biosciences segment (Clontech).

 
 
 
 
 
 
© Copyrights 2007, All Rights Reserved. FindMyBestCPA.com
Home     AboutUs     CPA Directory     List Your Firm     Links     Privacy     Contact Us